IMAGiNe study progress: 2025 highlights and what’s ahead

As we start a new year, we are excited to look back at what the IMAGiNe study achieved in 2025. We are also looking ahead to our goals for 2026 and beyond. At the Foundation for Peripheral Neuropathy (FPN), we celebrate every milestone that helps move peripheral neuropathy research forward.   About the IMAGiNe study  The IMAGiNe study (IgM Anti-Myelin-Associated Glycoprotein Neuropathy Study) is led by Maastricht University Medical […]

Read More… from IMAGiNe study progress: 2025 highlights and what’s ahead

Neuropathy News Dec. 2025

neuropathy news image

November was Diabetes Awareness Month Diabetes affects millions of people. It is a major cause of peripheral neuropathy. Last month, we shared information to help you understand how diabetes develops. We explained why it can damage nerves, and what you can do to stay healthy. Learning the signs early and managing blood sugar can lower […]

Read More… from Neuropathy News Dec. 2025

Neuropathy News Nov. 2025

neuropathy news image

Research update with Dr. Michelassi Francesco Michelassi, MD, PhD, Physician and Lead Scientist at the University of Virginia Health and the 2024 Clinical Research Training Scholarship (CRTS) recipient, shares his work studying Chemotherapy-Induced Peripheral Neuropathy (CIPN). He explains how his research could help protect nerves and lead to new treatments.  Learn how FPN helped Dr. […]

Read More… from Neuropathy News Nov. 2025

Neuropathy News Oct. 2025

FPN news

Celebrating Jack Miller, FPN’s founder on FPN Day Tomorrow, FPN celebrates its 18th anniversary. In honor of our founding, we are proud to celebrate Jack Miller, the man who founded the Foundation for Peripheral Neuropathy. In his previous patient story from 2011, Jack shared the complete history of why he started FPN and his own long journey with peripheral neuropathy. […]

Read More… from Neuropathy News Oct. 2025

FPN welcomes The Ohio State University as a new site for the IMAGiNe Study

The Foundation for Peripheral Neuropathy (FPN) is excited to share that The Ohio State University (OSU) has joined the IMAGiNe Study as a new research site. With help from FPN, OSU will take part in this international study about IgM anti-MAG peripheral neuropathy, a rare and often misunderstood nerve disease. About the IMAGiNe Study The […]

Read More… from FPN welcomes The Ohio State University as a new site for the IMAGiNe Study

Learn About the Latest in Peripheral Nerve Research

Edinburgh, Scotland

The Peripheral Nerve Society (PNS) is a global non-profit group made up of doctors, scientists, and healthcare workers. They study and treat diseases of the peripheral nervous system. Each year, the PNS hosts the PNS Annual Meeting. This event brings experts from around the world to share the newest research about peripheral nerve diseases. It’s […]

Read More… from Learn About the Latest in Peripheral Nerve Research

FY25 Peer Reviewed Medical Research Program (PRMRP) funding opportunities are now available!

For the fourth consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $150 million fund for FY25. In advance of pre-application deadlines, we are sharing the FY25 funding mechanisms, award amounts, maximum direct costs and how to apply. Want to learn more about […]

Read More… from FY25 Peer Reviewed Medical Research Program (PRMRP) funding opportunities are now available!

FY24 Peer Reviewed Medical Research Program (PRMRP) funding opportunities are now available!

FY24 Peer Reviewed Medical Research Program

For the fourth consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $370 million fund for FY24. In advance of pre-application deadlines, the Foundation for Peripheral Neuropathy (FPN) is sharing with you the FY24 funding mechanisms, award amounts, maximum direct costs and how to apply. FY24 […]

Read More… from FY24 Peer Reviewed Medical Research Program (PRMRP) funding opportunities are now available!

Have you been diagnosed with CIDP? A clinical research study (ARISE) is now enrolling to evaluate an investigational medication.

Janssen Arise

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disease where the body’s natural defenses, like antibodies, attack the covering of the nerves, called myelin, and damage nerve function. While symptoms aren’t the same for everyone, CIDP can make your arms and legs feel weak and slow your movements. The purpose of the ARISE Study is […]

Read More… from Have you been diagnosed with CIDP? A clinical research study (ARISE) is now enrolling to evaluate an investigational medication.

PERIPHERAL NEUROPATHY RESEARCHERS INVITED TO PRE-APPLY FOR RESEARCH GRANTS FROM DoD PEER REVIEWED MEDICAL RESEARCH PROGRAM

Advocacy works.

The Foundation for Peripheral Neuropathy and the Department of Defense Peer-Reviewed Medical Research Program Co-Host March 8, 2023, Webinar About Award Pre-Applications CHICAGO, Feb. 28, 2023 /PRNewswire/ — For the third consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $370 million fund. In advance of pre-application deadlines, the Foundation for Peripheral Neuropathy (FPN) […]

Read More… from PERIPHERAL NEUROPATHY RESEARCHERS INVITED TO PRE-APPLY FOR RESEARCH GRANTS FROM DoD PEER REVIEWED MEDICAL RESEARCH PROGRAM